High-Risk Reinsurance Pool For Medicare Rx Benefit Gaining Favor On Hill
Executive Summary
The Pharmaceutical Research & Manufacturers of America appears to be moving toward support for a high-risk reinsurance pool as part of a private insurance-based Medicare drug benefit proposal.
You may also be interested in...
Breaux Interim Medicare Rx Plan Would Cover Low-Income And Stop-Loss
An interim Medicare drug benefit being considered by Sen. Breaux (D-La.) would include both low-income and stop-loss subsidies, Breaux indicated at a March 22 Senate Finance Committee hearing.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011